Drug intelligence / Profile preview

PreserVision AREDS 2

Development stage: Unknown
Lead developer: Bausch + Lomb
Administration: Oral

Overview

PreserVision AREDS 2 is an eye vitamin and mineral supplement containing the exact clinically proven nutrient formula recommended by the National Eye Institute (NEI) based on the Age-Related Eye Disease Study 2 (AREDS 2). It is specifically formulated to help reduce the risk of progression in people with moderate-to-advanced age-related macular degeneration (AMD). The formula contains lutein, zeaxanthin, vitamin C, vitamin E, zinc, and copper. Some versions feature OCUSorb technology for 2X better nutrient absorption compared to the original formula.

Brand names: PreserVision AREDS 2
Other names: PreserVision AREDS 2 Formula

Beyond the preview

Go deeper on PreserVision AREDS 2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PreserVision AREDS 2.

Explore the full profile